🔎 Trials Near Me

Utama › Mieloma Pelbagai › Washington › Tacoma

Kajian klinikal Mieloma Pelbagai di Tacoma, WA

13 kajian untuk Mieloma Pelbagai sedang mencari peserta di lokasi dalam dan sekitar Tacoma (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.

Teks kajian rasmi (Bahasa Inggeris)

Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →

A Study Comparing AZD0120, a Dual-targeted CAR-T Against B-cell Maturation Antigen (BCMA) and CD19, Versus Standard Regimens in Participants With Relapsed Refractory Multiple Myeloma (DURGA-4)

Mengambil pesertaFasa 3
  • Research Site, Puyallup · 8 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 29 Sep 2026 · NCT07391657

A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma

Mengambil pesertaFasa 3
  • NorthWest Medical Specialties, PLLC, Tacoma
Umur 18 ke atas · Semua jantina · Dikemas kini 25 Sep 2026 · NCT07518186

Adult Outpatient Linvoseltamab With Tocilizumab Prophylaxis to Mitigate the Risk of Cytokine Release Syndrome (CRS)

Mengambil pesertaFasa 4
  • Northwest Medical Specialties, PLLC, Tacoma
Umur 18 ke atas · Semua jantina · Dikemas kini 25 Sep 2026 · NCT07609940

A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma

Mengambil pesertaFasa 3
  • NorthWest Medical Specialties, PLLC, Tacoma
Umur 18 ke atas · Semua jantina · Dikemas kini 25 Sep 2026 · NCT05552222

A Study to Compare the PK Characteristics, Safety, Tolerability, and Immunogenicity of HLX15-SC With DARZALEX FASPRO® in Combination With Lenalidomide and Dexamethasone (Rd) in Transplant-ineligible Patients With Newly Diagnosed Multiple Myeloma

Mengambil pesertaFasa 1
  • American Oncology Network Vista Oncology Division / Physician partner associate, Olympia · 26 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 24 Sep 2026 · NCT07477587

TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer

Mengambil pesertaFasa 2
  • Northwest Medical Specialties, Tacoma
  • Northwest Medical Specialties, Gig Harbor · 8 mi jauh
  • Northwest Medical Specialties, Puyallup · 8 mi jauh
  • dan 1 lagi
Umur 12 ke atas · Semua jantina · Dikemas kini 22 Sep 2026 · NCT02693535

A Study to Assess Adverse Events and Change in Disease Activity of Oral Surzetoclax Alone or in Combination With Subcutaneous and/or Oral Antimyeloma Agents in Adult Participants With Multiple Myeloma (MM)

Mengambil pesertaFasa 1/2
  • Northwest Medical Specialties Tacoma /ID# 272506, Tacoma
Umur 18 ke atas · Semua jantina · Dikemas kini 14 Sep 2026 · NCT06953960

A Study of an MMSET Inhibitor in Patients With Relapsed and Refractory Multiple Myeloma

Mengambil pesertaFasa 1
  • Northwest Medical Specialties, Tacoma
Umur 18 ke atas · Semua jantina · Dikemas kini 18 Ogo 2026 · NCT05651932

Study of AZD0120 in Newly Diagnosed Multiple Myeloma Ineligible for ASCT

Mengambil pesertaFasa 3
  • Research Site, Puyallup · 8 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 14 Ogo 2026 · NCT07764978

A Study to Assess Adverse Events of Intravenously (IV) Infused Etentamig (ABBV-383) in Adult Participants With Relapsed or Refractory Multiple Myeloma

Mengambil pesertaFasa 1
  • Northwest Medical Specialties Tacoma /ID# 267117, Tacoma
Umur 18 ke atas · Semua jantina · Dikemas kini 13 Jul 2026 · NCT05650632

Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatment

Mengambil pesertaFasa 3
  • Providence Regional Cancer System-Yelm, Yelm · 23 mi jauh
  • Providence Regional Cancer System-Lacey, Lacey · 23 mi jauh
Semua umur · Semua jantina · Dikemas kini 10 Jun 2026 · NCT05561387

Kajian Mieloma Pelbagai di bandar lain

Kajian lain di Tacoma

Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.